In type 2 diabetes, postprandial GLP-1 secretion may be reduced , leading to an impaired insulin response
Additionally, muscle injection creates localized pain, bruising, and potential nerve irritation that subcutaneous injection typically avoids
Therefore, these medicines cannot be used in people with a history or family history of medullary thyroid carcinoma (MTC) or in people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Next, multidrug chemotherapy was introduced with 23.5 mg cisplatin, 95 mg cyclophosphamide, 9.5 mg adriamycin, and 23.5 mg teniposide injected intravenously
doi: 10.1016/j.celrep.2021.109163 438 ChenJChiaNKalariKRYaoJZNovotnaMPaz SoldanMMet al
Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al